Abstract Library

#601 Chromogranin A is a Sensitive Marker of Progression or Regression

Introduction: One of the most common is gastroenteropancreatic (GEP) NET of the pancreas, which constitute about 30% of all GEP NET. CgA is an excellent marker for NET and tumor volume and plasma CgA is suggested as the most reliable marker in follow-up of GEP but only few studies have been published.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Jensen K

Authors: Jensen K, Hilsted L, Andersen J, Mynster T, Rehfeld J,

Keywords: Chromogranin A, pancreatic neuroendocrine tumors, neuroendocrine tumors, computered tomography, RECIST 1.1, radioimmunoassay,

#231 Chromogranin A as a Predictor of Progression, Regression or Stable Disease in Ileo-Cecal Neuroendocrine Tumors

Introduction: Chromogranin A is an excellent marker for NET and tumor volume. Plasma CgA is suggested as the most reliable marker in follow-up of patients with some types of NET.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Jensen K, Hilsted L, Jensen C, Mynster T, Knigge U,

Keywords: Chromogranin-A, carcinoid tumors, neuroendocrine tumors, computer tomography, RECIST 1.1,

#12 Chromogranin A as a predictor of progression, regression or stable disease in ileo-cecal (midgut) carcinoid tumors

Introduction: A general characteristic for NETs is their expression of certain proteins, such as chromogranin A (CgA), which is released from the dense core vesicles of NE cells, occasionally together with cell specific hormones, such as gastrin and serotonin. Plasma CgA seems to be closely related to tumor burden of intestinal carcinoid tumors in humans.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author:

Authors: Mynster T, Jensen K, Hilsted L, Knigge U,

Keywords: chromogranin-A, carcinoid tumors, neuroendocrine tumors, computered tomography, ultrasonography, octreotide scintigraphy, somatostatin receptors, radioimmunoassay,